MDxHealth, Merck KGaA Expand Glioblastoma Drug-CDx Deal
July 05, 2012
MDxHealth, Merck KGaA Expand Glioblastoma Drug-CDx Deal
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Foundation Medicine to Develop Dx for Agios Cancer Therapeutics
April 4, 2013 / GenomeWeb Daily News - Clarient to Offer Qiagen's Therascreen KRAS Assay as CDx for Erbitux
January 30, 2013 / GenomeWeb Daily News - Foundation Medicine, Clovis to Co-develop IVD for Drug Candidate
August 6, 2012 / GenomeWeb Daily News - Cancer Genetics to Provide Testing for Roche Servicios Oncology Program
August 2, 2012 / GenomeWeb Daily News - Merck KGaA, MDxHealth Explore Personalized Rx Strategy for Glioblastoma Patients with Methylated MGMT
July 11, 2012 / Pharmacogenomics Reporter